Medications containing semaglutide (such as Ozempic, Rybelsus, and Wegovy) and tirrizepatide (Mounjaro) have generated significant public interest due to their high efficacy in treating type 2 diabetes and obesity. Simultaneously, there has been an intensified search for information about products lacking sanitary authorization, which are being illegally sold online, posing health risks to consumers. This is demonstrated by the study "Health at …
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Medications containing semaglutide (such as Ozempic, Rybelsus, and Wegovy) and tirrizepatide (Mounjaro) have generated significant public interest due to their high efficacy in treating type 2 diabetes and obesity. Simultaneously, there has been an intensified search for information about products lacking sanitary authorization, which are being illegally sold online, posing health risks to consumers. This is demonstrated by the study "Health at …